Cite
Haring CT, Bhambhani C, Brummel C, et al. Human papilloma virus circulating tumor DNA assay predicts treatment response in recurrent/metastatic head and neck squamous cell carcinoma. Oncotarget. 2021;12(13):1214-1229doi: 10.18632/oncotarget.27992.
Haring, C. T., Bhambhani, C., Brummel, C., Jewell, B., Bellile, E., Heft Neal, M. E., Sandford, E., Spengler, R. M., Bhangale, A., Spector, M. E., McHugh, J., Prince, M. E., Mierzwa, M., Worden, F. P., Tewari, M., Swiecicki, P. L., & Brenner, J. C. (2021). Human papilloma virus circulating tumor DNA assay predicts treatment response in recurrent/metastatic head and neck squamous cell carcinoma. Oncotarget, 12(13), 1214-1229. https://doi.org/10.18632/oncotarget.27992
Haring, Catherine T, et al. "Human papilloma virus circulating tumor DNA assay predicts treatment response in recurrent/metastatic head and neck squamous cell carcinoma." Oncotarget vol. 12,13 (2021): 1214-1229. doi: https://doi.org/10.18632/oncotarget.27992
Haring CT, Bhambhani C, Brummel C, Jewell B, Bellile E, Heft Neal ME, Sandford E, Spengler RM, Bhangale A, Spector ME, McHugh J, Prince ME, Mierzwa M, Worden FP, Tewari M, Swiecicki PL, Brenner JC. Human papilloma virus circulating tumor DNA assay predicts treatment response in recurrent/metastatic head and neck squamous cell carcinoma. Oncotarget. 2021 Jun 22;12(13):1214-1229. doi: 10.18632/oncotarget.27992. eCollection 2021 Jun 22. PMID: 34194620; PMCID: PMC8238244.
Copy
Download .nbib